Cleerly News

Recent Press Highlights & Announcements

Latest News

Cleerly Named to Fierce Medtech's Fierce 15


March 7, 2022

Fierce Medtech names Cleerly one of its "Fierce 15" Med Tech Companies of 2021

Cleerly today announced that it has been named by Fierce Medtech as one of 2021’s Fierce 15 Med Tech Companies — recognizing venture-backed competitive companies championing innovation and creativity.

Read More

Cleerly Releases Software Update v2.2.0


February 9, 2022

Cleerly Takes Precision Heart Care to the Next Level With Cleerly 2.2.0

Cleerly, the company creating a new standard of care for heart disease, announced its latest product release, Cleerly 2.2.0, that includes user experience (UX) refinements and three new high-value tools.

Read More

Cleerly Named to NYCHBL Digital Health 150


February 2, 2022

Cleerly Named to NYC Digital Health 100 by New York City Health Business Leaders

New York City Health Business Leaders (NYCHBL), the organization that serves as the gateway to New York’s healthcare ecosystem, has recognized Cleerly on its NYC Digital Health 100, showcasing the most exciting and innovative health start-ups in New York.

Read More



December 8, 2021

Cleerly Named to the 2021 CB Insights Digital Health 150

CB Insights today named Cleerly to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world. This year’s Digital Health 150 was unveiled live during CB Insights’ annual Future of Health event.

Read More



November 9, 2021

Cleerly Expands Board of Directors with Three New Members

Kevin M. King, Glenn D. Steele Jr., MD, PhD and Roy Beveridge, MD have joined the board to advise the company as it works to identify individuals at the earliest stage to prevent heart attacks and save lives with its digital care pathway solution.

Read More



October 18, 2021

Cleerly Appoints Jim Hartman as Chief Revenue Officer

Sales strategy expert brings industry success to leverage growth.

Read More



September 29, 2021

Cleerly Expands Executive Team with Appointment of New Chief Operating Officer and Chief Technology Officer

Brandon Atkinson joins as COO and Nick Nieslanik as CTO to Support Company’s Mission to Create a New Standard of Care for Heart Disease, the Leading Cause of Death.

Read More



June 21, 2021

Cleerly Launches with $43 Million Series B to Provide a New Standard of Care for the Leading Cause of Death – Heart Disease

Resulting from More than a Decade of Clinical Research, Company Unveils Non-Invasive Approach to Identify, and New Care Pathways to Address Heart Disease Using Artificial Intelligence.

Read More

Press resources

If you are a member of the press and would like to speak with a Cleerly spokesperson, please reach out to us at


Stay Up-to-Date with Cleerly

Let's connect! Sign up to receive the latest Cleerly news, product information, and upcoming event.